Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Holt

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 1, 1997
[Not Available]D W Holt, A Johnston
Transplantation|September 10, 1999
TGF-beta quantitation can be trickyS Fredericks, D W Holt
British Medical Journal|March 15, 1975
Letter: Magnesium depletion and digoxin toxicityD W Holt, R Goulding
Transplantation Proceedings|September 2, 1998
Generic substitution for cyclosporine: what should we be looking for in new formulations?A Johnston, D W Holt
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Cyclosporin assay techniques. Accuracy and reproducibility variables impacting on measurementsD W Holt, A Johnston
Lancet (London, England)|September 14, 1991
Cyclosporin and vitamin ED W Holt, A Johnston
Arzneimittel-Forschung|November 1, 1995
Commentary on the publication of the study by Plavsić et al., "Bioequivalence of two oral cyclosporine preparations" in Arzneim.-Forsch./Drug Res. 45 (II), No.8, p. 914-917 (1995)D W Holt, A Johnston
Journal of Autoimmunity|April 1, 1992
Cyclosporin monitoring: its role in autoimmune indicationsD W Holt, A Johnston
Therapeutic Drug Monitoring|April 1, 1997
Tacrolimus quality assessmentD W Holt, A Johnston
Drug Metabolism and Drug Interactions|January 1, 1997
Monitoring new immunosuppressive agents. Are the methods adequate?D W Holt, A Johnston
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 1, 1997
[Not Available]D W Holt, A Johnston
Transplantation|September 10, 1999
TGF-beta quantitation can be trickyS Fredericks, D W Holt
British Medical Journal|March 15, 1975
Letter: Magnesium depletion and digoxin toxicityD W Holt, R Goulding
Transplantation Proceedings|September 2, 1998
Generic substitution for cyclosporine: what should we be looking for in new formulations?A Johnston, D W Holt
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Cyclosporin assay techniques. Accuracy and reproducibility variables impacting on measurementsD W Holt, A Johnston
Lancet (London, England)|September 14, 1991
Cyclosporin and vitamin ED W Holt, A Johnston
Arzneimittel-Forschung|November 1, 1995
Commentary on the publication of the study by Plavsić et al., "Bioequivalence of two oral cyclosporine preparations" in Arzneim.-Forsch./Drug Res. 45 (II), No.8, p. 914-917 (1995)D W Holt, A Johnston
Journal of Autoimmunity|April 1, 1992
Cyclosporin monitoring: its role in autoimmune indicationsD W Holt, A Johnston
Therapeutic Drug Monitoring|April 1, 1997
Tacrolimus quality assessmentD W Holt, A Johnston
Drug Metabolism and Drug Interactions|January 1, 1997
Monitoring new immunosuppressive agents. Are the methods adequate?D W Holt, A Johnston
Pageof 22